|
1 Indications And Usage Sublocade Is Indicated For The Treatment Of Moderate To Severe Opioid Use Disorder In Patients Who Have Initiated Treatment With A Transmucosal Buprenorphine-Containing Product, Followed By Dose Adjustment For A Minimum Of 7 Days. Sublocade Should Be Used As Part Of A Complete Treatment Plan That Includes Counseling And Psychosocial Support. Sublocade Contains Buprenorphine, A Partial Opioid Agonist, And Is Indicated For The Treatment Of Moderate To Severe Opioid Use Disorder In Patients Who Have Initiated Treatment With A Transmucosal Buprenorphine-Containing Product, Followed By Dose Adjustment For A Minimum Of 7 Days. ( 1 ) Sublocade Should Be Used As Part Of A Complete Treatment Program That Includes Counseling And Psychosocial Support. ( 1 )
|